Prescription Rules of Chinese Patent Medicines Containing Corydalis RhizomaLI Hongzheng, FU Changgeng, YU Zikai, YANG Wenwen, LONG Linzi, CHEN Keji3457-3463
Medication Rules of Ancient Physicians to Treat Heart Diseases with Modified Guizhi Decoction Based on Data MiningCHEN Miao, AN Dongqing3495-3507
Based on Data Mining to Explore the Medication Rules of Traditional Chinese Medicine in the Treatment of Angina Pectoris after PCI with Coronary Heart Disease of Qi Deficiency and Blood Stasis SyndromeLIU Zixian, BAO Yu, QIAO Lijie, ZHAO Jialin, PENG Guangcao, ZHU Mingjun3508-3514
Metabolomic Pathway Analysis of Coronary Heart Disease Patients with Phlegm Turbidity SyndromeCHEN Hao, LIANG Pan, REN Wei, YANG Sijin3515-3524
Effect of Qingre Huoxue Recipe on Myocardial Ischemia-reperfusion Injury Based on Network Pharmacology and Molecular DockingJI Shuliang, LI Rui, SUN Zhizhong, LIN Liwen, JI Xiaodong, WU Wei3531-3537
Effect of Shenlian Fumai Granules on Lipopolysaccharide-induced Polarization of RAW264.7 MacrophagesCAI Yun, XIN Qiqi, LIU Jing, GAO Qun, MIAO Yu, YUAN Rong, MA Zheng, PAN Yi, FAN Jiao, CONG Weihong, LIN Qian3542-3547
Effect and Mechanism of Danqi Pill on Regulating Ceramide Pathway in Improving Heart Failure after Myocardial Infarction in MiceTIAN Xue, CHEN Xu, ZHANG Yawen, JIANG Qianqian, JIANG Yanyan, SUN Qianbin, LIU Tiantian, SHAO Mingyan, MA Lin, WANG Yong3547-3553
Effects of Tianxiangdan on Microvascular Endothelial Structure and Function in Rats with Coronary Microcirculation DisordersGULIGENA Sawuer, LIU Wei, MA Xuekuan, AN Dongqing3554-3559
Effect and Mechanism of Kanli Granule on Inhibition of AngiotensinⅡInduced Hypertrophy of H9c2 CardiomyocytesLI Yue, WANG Xiaolong, YAO Chengzeng3560-3566
Meta-analysis of Three Yiqi-Yangyin-Huoxue Chinese Patent Medicine for Coronary Heart Disease Angina PectorisSHI Jiaxi, SHEN Qi, QIN Lijin, LIAO Weican, LIU Dongliang, WU Wei3587-3597
